Cipla Ltd Receives EIR For Invagen Facility

Following the inspection by the United States Food and Drug Administration (USFDA) at the Invagen (US) manufacturing facility from December 2, 2019 to December 6, 2019, the Company has received the Establishment Inspection Report (EIR), indicating closure of the inspection.

Shares of CIPLA LTD. was last trading in BSE at Rs.464.65 as compared to the previous close of Rs. 458.1. The total number of shares traded during the day was 101972 in over 3371 trades.

The stock hit an intraday high of Rs. 466.75 and intraday low of 454.9. The net turnover during the day was Rs. 47131661.-Equity Bulls